Zydus Lifesciences (ZYDUSLIFE) — Board Meeting

Zydus Lifesciences announced its board approved acquiring an 85.6% controlling stake in French medical device company Amplitude Surgical for €256.8 million (€6.25 per share), with plans to launch a mandatory cash tender offer for the remaining shares and pursue a squeeze-out delisting if successful. The acquisition targets Amplitude's specialty orthopaedic implants and surgical robotics portfolio to accelerate Zydus' MedTech expansion, leveraging its existing global distribution network and R&D capabilities in high-growth markets.

📄 View Original Announcement (PDF)

📊 Stock Analysis — ZYDUSLIFE ✨ Ask AI About This

About Zydus Lifesciences Limited (ZYDUSLIFE)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,01,800.69 Cr P/E: 22.5

View full ZYDUSLIFE stock details →

📡 Get AI alerts when ZYDUSLIFE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ZYDUSLIFE — Free

💡 Ask AI about this filing

"How does this board meeting affect Zydus Lifesciences Limited's outlook?" "What did Zydus Lifesciences Limited announce on 11 March 2025?" "Is this positive or negative for ZYDUSLIFE?"

Ask AI Free →

📊 More ZYDUSLIFE filings

See all ZYDUSLIFE filings →

🔥 Also filed on 11 March 2025

VBL Varun Beverages Limited Annual Report VBL Varun Beverages Limited Annual Report ICICIPRULI ICICI Prudential Life Insurance Company Limited Corporate Action AXISBANK Axis Bank Limited Corporate Action BHARTIARTL Bharti Airtel Limited Announcement ITC ITC Limited Voting Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ZYDUSLIFE files new disclosures

Track ZYDUSLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.